Ameritas Investment Partners, Inc. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$104,600
-13.5%
22,989
+33.8%
0.00%
-20.0%
Q2 2023$120,947
+75.1%
17,180
+51.9%
0.01%
+66.7%
Q1 2023$69,092
-12.7%
11,3080.0%0.00%0.0%
Q4 2022$79,156
-26.7%
11,3080.0%0.00%
-40.0%
Q3 2022$108,000
-12.9%
11,3080.0%0.01%0.0%
Q2 2022$124,000
-59.5%
11,308
+10.6%
0.01%
-70.6%
Q1 2020$306,000
+9.7%
10,222
+1.5%
0.02%
+41.7%
Q4 2019$279,000
+56.7%
10,075
+3.2%
0.01%
+50.0%
Q3 2019$178,000
-25.5%
9,7670.0%0.01%
-27.3%
Q2 2019$239,000
+188.0%
9,767
+11.5%
0.01%
+175.0%
Q1 2019$83,000
+6.4%
8,7580.0%0.00%0.0%
Q4 2018$78,000
-1.3%
8,758
+25.0%
0.00%0.0%
Q3 2018$79,000
-12.2%
7,0080.0%0.00%0.0%
Q2 2018$90,000
-14.3%
7,008
+12.6%
0.00%
-20.0%
Q1 2018$105,000
+183.8%
6,223
+35.5%
0.01%
+150.0%
Q4 2017$37,000
+42.3%
4,5910.0%0.00%
+100.0%
Q3 2017$26,000
-23.5%
4,5910.0%0.00%
-50.0%
Q2 2017$34,0004,5910.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 11,826,299$130,562,0004.09%
MPM BioImpact LLC 1,200,000$13,248,0003.68%
Finepoint Capital LP 960,200$10,601,0003.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 3,011$273,000,0002.85%
Avoro Capital Advisors LLC 9,220,000$101,789,0002.01%
Long Focus Capital Management, LLC 1,625,000$17,940,0001.88%
683 Capital Management, LLC 2,000,000$22,080,0001.56%
Parametrica Management Ltd 115,870$1,268,0001.38%
Boxer Capital, LLC 1,935,133$21,364,0001.35%
Soleus Capital Management, L.P. 719,600$7,944,0001.24%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders